Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AVEO

AVEO Pharmaceuticals (AVEO) Stock Price, News & Analysis

AVEO Pharmaceuticals logo

About AVEO Pharmaceuticals Stock (NASDAQ:AVEO)

Advanced Chart

Key Stats

Today's Range
$14.99
$15.00
50-Day Range
$14.90
$15.00
52-Week Range
$3.06
$15.00
Volume
247,800 shs
Average Volume
601,442 shs
Market Capitalization
$521.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVEO Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AVEO Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

AVEO Stock Analysis - Frequently Asked Questions

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) released its quarterly earnings data on Monday, November, 8th. The biopharmaceutical company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.06. The biopharmaceutical company had revenue of $15.17 million for the quarter, compared to analysts' expectations of $14.29 million. AVEO Pharmaceuticals had a negative net margin of 30.79% and a negative trailing twelve-month return on equity of 81.66%.

AVEO Pharmaceuticals's stock reverse split before market open on Thursday, February 20th 2020.The 1-10 reverse split was announced on Wednesday, February 19th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 19th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVEO Pharmaceuticals investors own include Advanced Micro Devices (AMD), Micron Technology (MU), OPKO Health (OPK), Alibaba Group (BABA), Meta Platforms (META), Exelixis (EXEL) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:AVEO
CIK
1325879
Employees
114
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($0.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.34 million
Net Margins
-30.79%
Pretax Margin
-30.79%
Return on Equity
-81.66%
Return on Assets
-28.83%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
2.37
Quick Ratio
2.35

Sales & Book Value

Annual Sales
$42.29 million
Price / Sales
12.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
11.28

Miscellaneous

Outstanding Shares
34,763,000
Free Float
33,619,000
Market Cap
$521.45 million
Optionable
Optionable
Beta
1.00

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AVEO) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners